title: The origin of cynomolgus monkey affects the outcome of kidney allografts under Neoral immunosuppression.
authors.affiliation: Transplantation Research, Novartis Pharma AG, Basel, Switzerland.
authors.forename: K
authors.initials: K
authors.lastname: Menninger
authors.forename: G
authors.initials: G
authors.lastname: Wieczorek
authors.forename: S
authors.initials: S
authors.lastname: Riesen
authors.forename: A
authors.initials: A
authors.lastname: Kunkler
authors.forename: M
authors.initials: M
authors.lastname: Audet
authors.forename: A
authors.initials: A
authors.lastname: Blancher
authors.forename: H-J
authors.initials: HJ
authors.lastname: Schuurman
authors.forename: V
authors.initials: V
authors.lastname: Quesniaux
authors.forename: M
authors.initials: M
authors.lastname: Bigaud
mesh_terms: D000818:Animals; D016572:Cyclosporine / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006085:Graft Survival / Q000502:physiology*; D006650:Histocompatibility Testing; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000502:physiology*; D007959:Lymphocyte Culture Test, Mixed; D008252:Macaca fascicularis; D008436:Mauritius; D023421:Models, Animal; D010679:Philippines; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine